Completed
Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529
NCT01342952
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
- Locations
-
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site Ann Arbor, Michigan, United States
- GSK Investigational Site New York, United States